N6-methyladenosine (m6A) is a widespread chemical modification of messenger RNA that influences how long transcripts persist in the cell. Early transcriptome-wide mapping by Samie Jaffrey at Weill Cornell Medicine revealed that m6A sites are enriched near stop codons and in 3' untranslated regions, positioning the mark to affect post-transcriptional fate. Chuan He at the University of Chicago further established that m6A is not static: specific enzymes can add and remove the mark, enabling dynamic regulation of mRNA stability.
Molecular mechanism
The effect of m6A on stability depends on an interplay among writers, erasers, and readers. The methyltransferase complex deposits m6A on nascent transcripts, while demethylases can remove it, creating a reversible modification that signals downstream pathways. Chuan He at the University of Chicago showed that proteins in the YTH domain family act as direct readers of m6A and translate the chemical information into functional outcomes. In particular, YTHDF2 recognizes m6A-modified mRNAs and recruits cellular decay machinery, accelerating transcript turnover. This recruitment often involves deadenylation complexes such as CCR4-NOT that shorten the poly(A) tail, a canonical step toward exonucleolytic degradation.
Mechanistically, the presence of m6A can alter local RNA structure and expose binding motifs for decay-promoting proteins, so the modification functions both as a physical change to the RNA and as a docking site for regulatory factors. Context matters: the same m6A site can have different outcomes depending on which reader proteins are expressed in a cell, the transcript’s subcellular localization, and competing RNA-binding proteins. Removal of m6A by demethylases reverses these signals and can stabilize transcripts that would otherwise be targeted for decay.
Biological consequences and contextual nuances
Because mRNA stability influences protein output, m6A-mediated control of decay has consequences for rapid cellular responses and long-term programmatic changes. Studies connecting m6A dynamics to differentiation and stress responses show that transient increases in m6A can promote the clearance of transcripts that maintain a prior cell state, enabling transitions in development and immune activation. In the brain, m6A patterns correlate with synaptic plasticity and neuronal gene expression, highlighting cultural and territorial nuances where different tissues or species prioritize distinct regulatory strategies.
Altered m6A regulation has been implicated in disease processes, including cancer and neurological disorders, where misregulation of writers, erasers, or readers changes transcript lifetimes and proteome composition. Interpretation of these links demands careful, reproducible experiments because the network of interactions is large and cell-type specific. Continued work by groups led by Samie Jaffrey at Weill Cornell Medicine and Chuan He at the University of Chicago, among others, is refining how m6A placement and recognition dictate mRNA lifespan and thus shape cellular behavior.